John S. Brusca

Array ( [id] => 4190313 [patent_doc_number] => 06130066 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Vectors having enhanced expression and methods of making and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/079587 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 22 [patent_no_of_words] => 34391 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130066.pdf [firstpage_image] =>[orig_patent_app_number] => 079587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221692 [patent_doc_number] => 06010907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Eukaryotic use of non-chimeric mutational vectors' [patent_app_type] => 1 [patent_app_number] => 9/078064 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8081 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010907.pdf [firstpage_image] =>[orig_patent_app_number] => 078064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079650 [patent_doc_number] => 06054278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Ribosomal RNA gene polymorphism based microorganism identification' [patent_app_type] => 1 [patent_app_number] => 9/073465 [patent_app_country] => US [patent_app_date] => 1998-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6335 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054278.pdf [firstpage_image] =>[orig_patent_app_number] => 073465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084549 [patent_doc_number] => 06017730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Method of limiting the survival of genetically engineered microorganisms in their environment' [patent_app_type] => 1 [patent_app_number] => 9/070964 [patent_app_country] => US [patent_app_date] => 1998-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 35853 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017730.pdf [firstpage_image] =>[orig_patent_app_number] => 070964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249034 [patent_doc_number] => 06207456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Nucleic acid delivery vehicle' [patent_app_type] => 1 [patent_app_number] => 9/029376 [patent_app_country] => US [patent_app_date] => 1998-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4890 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207456.pdf [firstpage_image] =>[orig_patent_app_number] => 029376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1427929 [patent_doc_number] => 06512981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Protein fold recognition using sequence-derived predictions' [patent_app_type] => B1 [patent_app_number] => 09/071279 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 8927 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512981.pdf [firstpage_image] =>[orig_patent_app_number] => 09071279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935603 [patent_doc_number] => 05981225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same' [patent_app_type] => 1 [patent_app_number] => 9/060828 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15276 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981225.pdf [firstpage_image] =>[orig_patent_app_number] => 060828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419634 [patent_doc_number] => 06225122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Human spinal cord cell lines and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 9/059790 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 22 [patent_no_of_words] => 8307 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225122.pdf [firstpage_image] =>[orig_patent_app_number] => 059790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1423484 [patent_doc_number] => 06535819 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Optimal dissimilarity method for choosing distinctive items of information from a large body of information' [patent_app_type] => B1 [patent_app_number] => 09/059017 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9476 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/535/06535819.pdf [firstpage_image] =>[orig_patent_app_number] => 09059017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484681 [patent_doc_number] => 06365347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Method for identifying disruptors of biological pathways using genetic selection' [patent_app_type] => B1 [patent_app_number] => 09/058483 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 17137 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365347.pdf [firstpage_image] =>[orig_patent_app_number] => 09058483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093416 [patent_doc_number] => 06066123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Enhancement of bioavailability by use of focused energy delivery to a target tissue' [patent_app_type] => 1 [patent_app_number] => 9/057862 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 9384 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066123.pdf [firstpage_image] =>[orig_patent_app_number] => 057862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493848 [patent_doc_number] => 06342345 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Detection of molecular interactions by reporter subunit complementation' [patent_app_type] => B1 [patent_app_number] => 09/053614 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 19487 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342345.pdf [firstpage_image] =>[orig_patent_app_number] => 09053614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084084 [patent_doc_number] => 06025197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Secreted salivary zsig32 polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/040786 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28932 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025197.pdf [firstpage_image] =>[orig_patent_app_number] => 040786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565439 [patent_doc_number] => 06376248 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Peptide-enhanced transfections' [patent_app_type] => B1 [patent_app_number] => 09/039780 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37226 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376248.pdf [firstpage_image] =>[orig_patent_app_number] => 09039780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046805 [patent_doc_number] => 05968803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Human DNA topoisomerase I .alpha.' [patent_app_type] => 1 [patent_app_number] => 9/033153 [patent_app_country] => US [patent_app_date] => 1998-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12130 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968803.pdf [firstpage_image] =>[orig_patent_app_number] => 033153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4145002 [patent_doc_number] => 06063627 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Methods and vectors for site-specific recombination' [patent_app_type] => 1 [patent_app_number] => 9/030563 [patent_app_country] => US [patent_app_date] => 1998-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 50 [patent_no_of_words] => 23319 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063627.pdf [firstpage_image] =>[orig_patent_app_number] => 030563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151796 [patent_doc_number] => 06107057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Pichia secretory leader for protein expression' [patent_app_type] => 1 [patent_app_number] => 9/029267 [patent_app_country] => US [patent_app_date] => 1998-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11983 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107057.pdf [firstpage_image] =>[orig_patent_app_number] => 029267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137585 [patent_doc_number] => 06060248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Process for selecting anti-sense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/028201 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3668 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060248.pdf [firstpage_image] =>[orig_patent_app_number] => 028201 [rel_patent_id] =>[rel_patent_doc_number] =>)